“The worst part of this story is that if CytoDyn
Post# of 148181
(Total Views: 491)
Posted On: 10/18/2020 6:46:30 PM
“The worst part of this story is that if CytoDyn had simply done this, we'd only need 87.64 patients to achieve full enrollment. And at an enrollment rate of 1.98 patients per day, we would have achieved full enrollment in 44.26 days on December 1. And extending that to its logical conclusion, the fully-enrolled trial would be have been completely over 28 days later on December 29.”
I doubt we’ll ever know, but I’d be interested to understand the various factors that have contributed to slow enrollment. I’ve always attributed it to fewer clinical sites, funding restrictions, and competition with other trials. If the efficacy is there, as we expect it to be, CYDY should throw even more resources at increasing enrollment.
I doubt we’ll ever know, but I’d be interested to understand the various factors that have contributed to slow enrollment. I’ve always attributed it to fewer clinical sites, funding restrictions, and competition with other trials. If the efficacy is there, as we expect it to be, CYDY should throw even more resources at increasing enrollment.
(1)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼